Cheaper medicines with twice as many medicines now available for a 60 day prescription

3 March 2024 - The Albanese Government is making medicines cheaper by doubling the number of medicines now available for ...

Read more →

Australians with chronic heart failure benefit from cheaper medicines on the PBS

3 March 2024 - Australians with chronic heart failure now have access to cheaper medicines under the PBS. ...

Read more →

Patisiran sodium in hereditary transthyretin amyloidosis: less benefit than vutrisiran

1 March 2024 - In 2023, IQWiG found an additional benefit of vutrisiran compared to patisiran sodium based on a study.  ...

Read more →

Public Summary Documents – November 2023 PBAC meeting (round 1)

1 March 2024 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the November 2023 PBAC ...

Read more →

More rare conditions considered for newborn bloodspot screening and new treatment option for spinal muscular atrophy

29 February 2024 - On Rare Disease Day, the Albanese Government has announced two more rare genetic conditions have been ...

Read more →

Collaborating to help improve access to drugs for rare diseases

29 February 2024 - On Rare Disease Day — a day when the international community raises awareness about rare conditions ...

Read more →

Schedule of Pharmaceutical Benefits - 1 March 2024

1 March 2024 - The March 2024 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

Read more →

New Zealand Pharmaceutical Schedule - 1 March 2024

1 March 2024 - The March 2024 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...

Read more →

Today is Rare Disease Day

29 February 2024 - PHARMAC understands that people living with rare disorders face many challenges, including access to health care ...

Read more →

Minister announces parallel assessment means new medicines assessed sooner

28 February 2024 - PHARMAC is changing its process so it can assess a funding application at the same time Medsafe ...

Read more →

Etrasimod arginine for the treatment of patients with moderate to severe active ulcerative colitis

27 February 2024 - NICE has published final evidence-based recommendations on the use of etrasimod arginine (Velsipity) for the treatment ...

Read more →

Voxelotor for the treatment of patients with sickle cell disease (draft guidance)

27 February 2024 - NICE has issued further draft guidance on the use of voxelotor following an appeal hearing in ...

Read more →

Tafamidis for the treatment of patients with transthyretin amyloidosis with cardiomyopathy

27 February 2024 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...

Read more →

Setmelanotide acetate for the treatment of people with obesity and hyperphagia associated with Bardet-Biedl syndrome (draft guidance)

22 February 2024 - NICE has published further draft guidance on the use of setmelanotide acetate. ...

Read more →

Drug insurance: a single payer pharmacare program would jeopardise coverage quality for 21 million Canadians

22 February 2024 - Imposing a single payer universal drug insurance plan on all Canadians would jeopardise coverage quality for ...

Read more →